Literature DB >> 26373273

The Amazing and Deadly Glioma Race.

Vijay Ramaswamy1, Michael D Taylor2.   

Abstract

In this issue of Cancer Cell, studies from Mazor and colleagues and Kim and colleagues use a combination of epigenetic and genetic approaches to reveal a complex evolutionary process underlying two of the biggest challenges facing neuro-oncology, specifically glioblastoma malignant progression and treatment resistance.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26373273     DOI: 10.1016/j.ccell.2015.08.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  4 in total

1.  Nogo-A/NgR signaling regulates stemness in cancer stem-like cells derived from U87MG glioblastoma cells.

Authors:  Chengjin Ai; Yu Zhou; Kunming Pu; Yi Yang; Yingying Zhou
Journal:  Oncol Lett       Date:  2022-05-27       Impact factor: 3.111

2.  miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.

Authors:  Hang Song; Yao Zhang; Na Liu; Sheng Zhao; Yan Kong; Liudi Yuan
Journal:  Int J Mol Sci       Date:  2016-10-27       Impact factor: 5.923

3.  Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.

Authors:  Ting Sun; Yanyan Li; Yulun Huang; Zizhu Zhang; Weilian Yang; Ziwei Du; Youxin Zhou
Journal:  Oncotarget       Date:  2016-07-12

4.  The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection.

Authors:  Andrea M Muscat; Nicholas C Wong; Katharine J Drummond; Elizabeth M Algar; Mustafa Khasraw; Roel Verhaak; Kathryn Field; Mark A Rosenthal; David M Ashley
Journal:  Oncotarget       Date:  2017-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.